1,169 results on '"Grimminger, F."'
Search Results
2. Long-term Exposure to E-cigarette Vapour In Vivo Induced Inflammation and Structural Alterations in the Lungs
3. Cell-specific Noxo1 Deletion in a Mouse Model of Cigarette Smoke-induced Emphysema and Pulmonary Hypertension
4. Cellular and Molecular Mechanisms Underlying FGF10-mediated Reversion of Experimental Emphysema and Pulmonary Hypertension in Mice
5. CEACAM6 as a Determinant of Lung Epithelial Cell Fate Upon Cigarette Smoke Exposure
6. The Role of Classical Transient Receptor Potential Channels in the Regulation of Hypoxic Pulmonary Vasoconstriction
7. Lungengefäßerkrankungen
8. Lungenparenchymerkrankungen
9. Mediatorblockade und Immunmodulation — Konzepte und Praxisreifes
10. Akute und chronische respiratorische Insuffizienz
11. Impaired FGF10 Signaling Is Involved in the Development of Pulmonary Parenchymal and Vascular Remodeling
12. Omega-3 Fatty Acid Expression Attenuates Chronic Hypoxia-Induced and Smoke-Induced Pulmonary Hypertension
13. MAP Kinase Mediated Cross-Talk Between Macrophages and Pulmonary Artery Smooth Muscle Cells Is Essential for Tobacco Smoke-Induced Pulmonary Vascular Remodeling
14. The Role of Mitochondrial Cytochrome Coxidase Subunit 4 Isoform 2 (Cox4i2) in Acute Pulmonary Oxygen Sensing
15. CEACAM6 Impedes the HO-1-Mediated Defence Against Nitrosative/Oxidative Stress in COPD
16. Akute und chronische respiratorische Insuffizienz
17. Surfactant-Therapie für das akute Lungenversagen (ARDS)
18. Pneumonie und Abszess
19. Fehlbildungen der Lungengefäße
20. Lungenödem und akutes respiratorisches Distress-Syndrom (ARDS)
21. Lungenembolien
22. Pulmonale Hypertonie
23. Mediatorblockade in der Sepsis: Inhibitoren, Antagonisten und Antikörper
24. Akute und chronische respiratorische Insuffizienz
25. Medikamentöse Therapie der pulmonalen Hypertonie: Was ist neu?
26. Alteration of Pulmonary Surfactant in Ards - Pathogenetic Role and Therapeutic Perspectives
27. Pathogenesis of Sepsis Syndrome: Possible Relevance of Pore-Forming Bacterial Toxins
28. Mediatorblockade (Mediatorinhibitoren, -antagonisten, -antikörper)
29. Inflammation, immunological reaction and role of infection in pulmonary hypertension
30. Bacterial Exotoxins and Sepsis
31. Mediatorblockade (Mediatorinhibitoren, -antagonisten, -antikörper)
32. Bacterial Exotoxins and Vascular Injury
33. Eicosanoids and Acute Respiratory Failure — Pathophysiologic and Therapeutic Aspects
34. Bacterial Exotoxins and Acute Lung Failure
35. Die Rolle von Arachidonsäuremetaboliten in der Pathogenese des Asthma bronchiale
36. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF
37. Supplement to: Riociguat for the treatment of chronic thromboembolic pulmonary hypertension.
38. Supplement to: Riociguat for the treatment of pulmonary arterial hypertension.
39. Aktuelle Therapie der pulmonal-arteriellen Hypertonie
40. Therapie der pulmonalarteriellen Hypertonie
41. Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer model
42. Non-invasiv quantifiziertes RV-PA Coupling als unabhängiger Prädiktor für das Überleben beim NSCLC.
43. TriFinger: An Open-Source Robot for Learning Dexterity
44. Ernährung und Immunonutrition bei Sepsis
45. Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients
46. Medikamentöse Therapie der pulmonalen Hypertonie
47. Simvastatin inhibits Staphylococcus aureus alpha toxin mediated polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction
48. Pulmonaler Hochdruck
49. Schwere Sepsis – neue Therapieverfahren
50. Surfactant-Therapie für das akute Lungenversagen (ARDS)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.